Yona Levites, AD/PD 2021: Immunotherapeutic approaches in Alzheimer’s Disease (Part 2)

We had the pleasure of meeting with Yona Levites (Center for Translational Research in Neurodegenerative Disease, University of Florida, Gainesville, FL, USA ) to discuss her phase 1 study investigating the scFv-CD protein as a framework for identifying an optimized immunotherapy for Alzheimer’s Disease, and potentially other neurodegenerative disorders.

Part 1 of the discussion can be viewed here.

The abstract entitled ‘Immunotherapeutic approaches in Alzheimer’s Disease’ was presented at The 15th International Conference for Alzheimer’s & Parkinson’s Diseases (Virtual), March 8-14, 2021.

Questions:

1. Could you give us a brief description of the scFv-CD protein you have developed? (0:20)
2. What have you learned from preclinical studies of the scFv-CD protein? (2:06)

Disclosures: Yona Levites has nothing to disclose in relation to this video.

Support: Interview and filming supported by Touch Medical Media.

Filmed as a highlight of AD/PD Virtual 2021.